Research / September 26, 2026

The source notes.

Public records, with their limits beside them. Provider pages establish advertised offers; they do not independently prove treatment outcomes.

01 / Provider offer

CoreAge Rx: Smooth Move ↗

Expanded PDP describes tretinoin, niacinamide and vitamin C roles and links to the current product-specific sales page. No numerical strengths or exact-mixture trial established.

Checked 2026-09-27

02 / Provider offer

Nurx: tretinoin cream ↗

Generic Retin-A presentation, $90 three-month medicine supply and insurance distinctions; not a final personal quote.

Checked 2026-09-26

03 / Provider terms

Nurx: anti-aging treatment cost ↗

Separate $30 consultation, three-month refills and free shipping; read alongside the broader fee policy.

Checked 2026-09-26

04 / Provider terms

Nurx: complete service pricing ↗

$3 support fee in months when an order is processed and anti-aging consultation terms; other services have different fees.

Checked 2026-09-26

05 / Provider offer

Musely: The Anti-Aging Cream ↗

Current $35 monthly presentation, two-month auto-refill supply, formula panel and self-reported outcomes; no independent trial audit.

Checked 2026-09-26

06 / Provider terms

Musely: 60-Day Result Guarantee ↗

Conditions, initial-order limitation and referenced $20 doctor fee; a refund policy is not a clinical guarantee.

Checked 2026-09-26

07 / Provider offer

Dear Brightly: Night Shift ↗

$66 two-month trial, $99 quarterly refills and tretinoin plus niacinamide serum; eligibility requires assessment.

Checked 2026-09-26

08 / Provider terms

Dear Brightly: frequently asked questions ↗

Compounding, formulation details, refill timing and cancellation cutoffs. Follow the dispensing pharmacy on storage questions.

Checked 2026-09-26

09 / Medical reference

MedlinePlus: topical tretinoin ↗

General medicine uses and precautions; not evidence of comparative effectiveness between reviewed providers.

Checked 2026-09-27

10 / Regulatory reference

FDA: understanding compounded-drug risks ↗

Compounded preparations do not have FDA premarket approval; general category information is not a finding against a named pharmacy.

Checked 2026-09-27

11 / Regulatory reference

FDA: compounding questions and answers ↗

Approved generics and compounded preparations are different categories; clinical need matters.

Checked 2026-09-26

12 / Regulatory reference

FDA: locate a state-licensed pharmacy ↗

State-board links and consumer checks; this publication has not audited all dispensers.

Checked 2026-09-26

13 / Medical reference

AAD: retinoid or retinol? ↗

Retinoid distinctions and irritation considerations; percentages are not a consumer conversion chart.

Checked 2026-10-14

14 / Medical reference

AAD: pregnancy skin care ↗

Retinoids, including tretinoin, are ingredients to avoid during pregnancy; discuss individual circumstances with clinicians.

Checked 2026-09-26

15 / Medical reference

AAD: skin care during menopause ↗

Changing skin concerns and care priorities; age alone does not determine a prescription.

Checked 2026-09-26

16 / Provider offer

Twyneo: current manufacturer product page ↗

Current 0.1% tretinoin/3% benzoyl peroxide acne product and manufacturer link to the February 2025 prescribing information. Marketing speed and convenience language is not a comparative clinical ranking.

Checked 2026-09-26

17 / Provider terms

Twyneo: savings and support ↗

September 26, 2026 page advertises possible $0 commercially insured/$45 uninsured program pricing, subject to eligibility, participating pharmacies and government-plan exclusions. No personal benefit or final charge verified.

Checked 2026-09-26

18 / Regulatory reference

DailyMed: current Twyneo prescribing information ↗

Label revised February 2025, record updated August 11, 2025. Acne indication age nine and older, separate microencapsulation, vehicle-controlled trials, hypersensitivity precautions and dual discard limits. This is the manufacturer-linked current record, not the older search-result label.

Checked 2026-09-26

19 / Provider terms

Twyneo: current frequently asked questions ↗

Useful product and access context. Its opening-date storage summary is shorter than the complete label, which also includes the dispensing-date limit; the article preserves the full label distinction.

Checked 2026-09-26

20 / Regulatory reference

DailyMed: Retin-A Micro gel prescribing information ↗

September 2025 record: four strengths, acne indication age twelve and older, microsphere formulation and strength-specific study descriptions. Some package entries have marketing end dates; no current stock or pharmacy quote established. Older repackager record excluded from current claims.

Checked 2026-09-26

21 / Medical reference

AAD: medical patch testing for an allergic rash ↗

Explains clinician-directed testing for suspected delayed contact allergy. Does not validate a home prescription test, diagnose a reader’s rash or prove every reaction is allergic.

Checked 2026-09-27

22 / Regulatory reference

FDA: generic drugs questions and answers ↗

Approved-generic equivalence standards and possible differences in inactive ingredients or appearance. These principles are not a substitution decision for two particular products and do not confer approval on compounds.

Checked 2026-09-26

23 / Regulatory reference

FDA BeSafeRx: considering an online pharmacy ↗

Prescription, licensing, pharmacist-contact and consumer warning signs. Used with official state-board links; this publication does not claim it audited every reviewed service or dispenser.

Checked 2026-09-26

24 / Drug label

DailyMed: Retin-A cream and gel labeling ↗

Bausch record updated May 17, 2024; cream and gel formulations must be distinguished. Establishes product information and precautions, not current stock, pharmacy price or comparative superiority.

Checked 2026-09-27

25 / Clinical guidance

AAD: seven rosacea skin-care tips ↗

April 9, 2024 public guidance on symptoms and gentle care. Similar symptoms require diagnosis; no AAD endorsement of featured providers and no home testing instructions for prescription tretinoin are inferred.

Checked 2026-09-27

26 / Regulatory guidance

FDA: sunscreen and sun protection ↗

Explains SPF, broad spectrum, water resistance and storage. Sunscreen does not establish readiness to restart a prescription on injured skin.

Checked 2026-09-27

27 / Clinical guidance

AAD: how to apply sunscreen ↗

Page updated August 15, 2025. General selection, coverage and reapplication advice; not an individualized prescription or evidence for a particular compounded product.

Checked 2026-09-27

28 / Drug label

DailyMed: Refissa emollient tretinoin cream 0.05% record ↗

Record updated January 8, 2014; flags inactivated NDCs. Formula, bounded indication, 24-week evidence and population limits reviewed. No current distribution, stock or pharmacy price confirmed.

Checked 2026-09-27

29 / Original research

Bhawan and colleagues: effects of tretinoin on photodamaged skin ↗

1991 original report; public abstract reviewed. Two controlled studies, 533 subjects, 24-week biopsies: epidermal changes and no obvious dermal changes reported. Full methods and individual response cannot be inferred; erratum noted in record.

Checked 2026-09-27

30 / Original research

Kircik: twelve-month histologic study of tretinoin emollient cream ↗

September 2012 abstract and accessible first-page methods: three biopsied participants from19, open-label uncontrolled observation. Not comparative proof or an outcome frequency; broad regulatory wording in its introduction is not adopted.

Checked 2026-09-27

31 / Clinical reference

MedlinePlus: aging changes in skin ↗

Skin-layer anatomy and aging context, not a diagnosis of an individual reaction or evidence that a specific tretinoin preparation prevents injury.

Checked 2026-09-27

32 / Provider

CoreAge Rx: Smooth Move supply plans ↗

Current final destination lists $504/12 months under $42/month; $300/six, $168/three and $70/one. Displayed monthly rounding differs. No checkout tested; strengths absent; promotional claims remain separate from finished-formula evidence.

Checked 2026-09-27

33 / Provider offer

Likeness Rx — Fine Line Cream ↗

Official product ingredients, displayed prices and subscription renewal, checked October 4, 2026. No patient care or fulfillment test performed.

Checked 2026-10-04

34 / Provider shipping reference and supplied service information

CoreAge Rx: shipping and service information ↗

Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test

Checked 2026-10-12

35 / Official product or purchase terms